FindTrial
Sign In

Long-term assessment of peroral cholangioscopy in the diagnosis and treatment of intraductal papillary neoplasms of the bile duct

Long-term assessment of the added value of peroral cholangioscopy in the diagnosis and treatment of intraductal papillary neoplasms of the bile duct

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010599
Enrollment
85
Registered
2025-06-09
Start date
2025-06-10
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Soonchunhyang University Hospital Bucheon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Patients aged =19 and <80 years ? Patients who underwent cholangioscopy due to suspected biliary disease ? Patients with a history of endoscopic sphincterotomy or endoscopic papillary balloon dilation

Exclusion criteria

Exclusion criteria: ? Bleeding tendency (international normalized ratio>1.5 < 50000 mm3) ? Contraindication of endoscopic retrograde cholangiopancreatography (ERCP)

Design outcomes

Primary

MeasureTime frame
Detection rate of IPN-Bs—

Secondary

MeasureTime frame
Technical success of POC;Technical success of POC-guided forceps biopsy;Adverse events—

Countries

Korea, Republic of

Contacts

Public ContactIl Sang Shin

Soon Chun Hyang University Hospital Bucheon

110554@schmc.ac.kr+82-32-621-5094

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026